en · de · es · fr · pt
tb-500-notes.peptides4800.com › Faq › Identity And Physical Form — Reference Sheet

Identity And Physical Form — Reference Sheet

By Editorial Desk · published 2026-07-10 · last reviewed 2026-08-01 · Faq

This is a working overview of reverse-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.

Identity and Physical Form

Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.

The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.

The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.

Handling, Storage, and Quality Control

Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.

Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.

Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.

Tb-500 at a glance

PropertyValueNotes
Molecular mass≈889 Da for the 7-residue fragmentFull-length thymosin beta-4 is ≈4.9 kDa; catalogs differ
AppearanceWhite to off-white powderHygroscopic; weight shifts with residual moisture
Solubility classFreely soluble in waterAlso dissolves in aqueous buffers; poorly soluble in nonpolar solvents
Typical storage temperature−20 °C, desiccated, protected from lightOnce rehydrated, short-term holding at 2-8 °C
Typical analytical methodReversed-phase HPLC with mass spectrometryPurity by UV absorbance; identity by ESI-MS or MALDI-TOF

TB-500 Background and Identity

Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.

TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.

Related pages on this site

Identity And Naming Background

Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.

TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.

Handling, Storage, and Analytical Verification

Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.

Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.

The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.

Thymosin Beta-4 Fragment Overview

The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.

TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.

Supporting material

The alien conspiracy theory and queer ladder of mobility theories state that ethnicity and 'outsider' status (immigrants, or those not within the dominant ethnocentric groups) and their influences are thought to dictate the prevalence of organized crime in society. The alien theory posits that the contemporary structures of organized crime gained prominence during the 1860s in Sicily and that elements of the Sicilian population are responsible for the foundation of most European and North American organized crime, made up of Italian-dominated crime families. Bell's theory of the 'queer ladder of mobility' hypothesized that 'ethnic succession' (the attainment of power and control by one more marginalized ethnic group over other less marginalized groups) occurs by promoting the perpetration of criminal activities within a disenfranchised or oppressed demographic. Whilst early organized crime was dominated by the Irish Mob (early 1800s), they were relatively substituted by the Sicilian Mafia and Italian-American Mafia, the Aryan Brotherhood (1960s onward), Colombian Medellín Cartel and Cali cartel (mid-1970s - 1990s), and more recently the Mexican Tijuana Cartel (late 1980s onward), Mexican Los Zetas (late 1990s to onward), the Russian Mafia (1988 onward), terrorism-related organized crime Al-Qaeda (1988 onward), the Taliban (1994 onward), and Islamic State of Iraq and the Levant (ISIL) (2010s to onward). Many argue this misinterprets and overstates the role of ethnicity in organized crime.

In November 1993, relator Robert Marena, an SKB employee, filed a qui tam action against GlaxoSmithKline in the United States District Court for the Eastern District of Pennsylvania. His complaint contained eight separate claims under the False Claims Act. Merena's complaint alleged that SKB had defrauded the government by, inter alia, billing for tests that were not performed, double billing, paying illegal kickbacks to health care professionals, and adding tests to "automated chemistry" profiles and then separately billing for those tests. After a month, relator Glenn Grossenbacher, an attorney, filed a second qui tam action against GlaxoSmithKline in the United States District Court for the Western District of Texas. Relators Kevin Spear, Jack Dowden, and the Berkeley Community Law Center (collectively, "the Spear relators") followed in February 1995 with a suit in the Northern District of California. The courts in Texas and California transferred these actions to the Eastern District of Pennsylvania for consolidation with the Merena case. After Merena's action was filed, the government commenced an investigation into a series of new claims that were not part of its original investigation. At the same time, the government continued to pursue the original "automated chemistry" investigation that it had begun after the 1992 settlement with National Health Laboratories. Later in August 1995, the government began formal settlement negotiations with GlaxoSmithKline.

This is a list of notable women mass spectrometrists with significant scientific contribution towards advancement in theories, instrumentation and applications of mass spectrometry. The list is organized by the chemical societies and their major awards related to mass spectrometry, as well as presidency.

October 5–10, 1908 - The rapidly growing, global industry and scientific quest for absolute zero led to the 1st International Congress of Refrigeration held in Paris, France, at the Paris-Sorbonne University, which welcomed over 5,000 participants. January 25, 1909 - From this first Congress, the International Association of Refrigeration was born, formed by delegates from 35 countries. June 21, 1920 - The association was reorganised and officially titled as the International Institute of Refrigeration – IIR (Institut International du Froid – IIF, in French). IIR's status as an international organisation was defined by an International Agreement signed on December 1, 1954, and General Regulations for the Application of the International Agreements signed on November 20, 1956. Since then, the IIR has been operating at its headquarters based in Paris and is now an international organisation for expertise on refrigeration. The institute has continued to run the International Congress of Refrigeration every four years since its inauguration and has now expanded its event portfolio to ten conference series covering a wide variety of refrigeration topics. Working alongside governments, today the IIR remains committed to promoting knowledge on refrigeration for sustainable development, and continues to provide key services to disseminate information on associated technologies to all stakeholders (companies, universities, professionals, etc.).

Sources: en.wikipedia.org

Supporting material

== Visibility to humans == The lens of the human eye and surgically implanted lenses block most radiation in the near UV wavelength range of 300–400 nm; shorter wavelengths are blocked by the cornea. Humans also lack color receptor adaptations for ultraviolet rays. However, the photoreceptors of the human retina are quite sensitive to UVA photons but the lens does not focus this light properly, causing UVA light bulbs to look fuzzy. People lacking a lens (a condition known as aphakia) perceive UVA as whitish-blue or whitish-violet. Near-UV radiation is visible to insects, some mammals, and some birds. Birds have a fourth color receptor for ultraviolet rays; this, coupled with eye structures that transmit more UV gives smaller birds "true" UV vision.

A photograph of the deceased in good health is often sought to guide the embalmer's hand in restoring the body to a more lifelike appearance. Blemishes and discolorations (such as bruises, in which the discoloration is not in the circulatory system, and cannot be removed by arterial injection) occasioned by the last illness, the settling of blood, or the embalming process itself are also dealt with at this time (although some embalmers utilize hypodermic bleaching agents, such as phenol-based cauterants, during injection to lighten discoloration and allow easier cosmeticizing). It is also common for the embalmer to perform minor restoration of the deceased's appearance with tissue building chemicals and a hypodermic syringe. Tissue building chemicals (Tissue Builders) become solid with the introduction of liquids such as water or interstitial fluids. Commonly the area where the sphenoid and temporal bones meet; this can also be referred to the temples. In the event of trauma or natural depressions on the face or hands, tissue builder can also be utilised to return those regions of the face to the expectations of the family.

==== Roman writers ==== Aulus Cornelius Celsus (fl. 30 BC – 50 AD), who interpreted Greek works in Latin, provided an early clinical description of diabetes in his eight-volume work titled De Medicina. He wrote that "urine exceeds in quantity the fluid taken even if it is passed painlessly." This concept of an imbalance between the ingested and excreted amounts of fluid was repeated by many authors into the Middle Ages. Rufus of Ephesus (fl. 98–117 AD), a physician famous for his work on the variations of the pulse, described the symptoms of diabetes as "incessant thirst" and immediate urination after drinking, which he called "urinary diarrhea".

== Measurement == Further information: Thyroid function tests Triiodothyronine (T3) and thyroxine (T4) can be measured as free T3 and free T4, which are indicators of their activities in the body. They can also be measured as total T3 and total T4, which depend on the amount that is bound to thyroxine-binding globulin (TBG). A related parameter is the free thyroxine index, which is total T4 multiplied by thyroid hormone uptake, which, in turn, is a measure of the unbound TBG. Additionally, thyroid disorders can be detected prenatally using advanced imaging techniques and testing fetal hormone levels.

== Nomenclature == Perfluorocarbons or PFCs, are organofluorine compounds with the formula CxFy, meaning they contain only carbon and fluorine. The terminology is not strictly followed and many fluorine-containing organic compounds are also called fluorocarbons. Compounds with the prefix perfluoro- are hydrocarbons, including those with heteroatoms, wherein all C-H bonds have been replaced by C-F bonds. Fluorocarbons includes perfluoroalkanes, fluoroalkenes, fluoroalkynes, and perfluoroaromatic compounds.

Sources: en.wikipedia.org

Notes from published material

The 5' terminus of the splint is designed to be complementary to the 3' end of the mRNA, and the 3' terminus of the splint is designed to be complementary to the 5' end of the DNA spacer linker, which usually consists of poly dA nucleotides (Figure 2).

A mammal (from Latin mamma 'breast') is a vertebrate animal of the class Mammalia (). Mammals are characterized by the presence of milk-producing mammary glands for feeding their young, a broad neocortex region of the brain, fur or hair, and three middle ear bones. These characteristics distinguish them from reptiles and birds, from which their ancestors diverged in the Carboniferous period over 300 million years ago. Around 6,640 extant species of mammals have been described and divided into 27 orders. The study of mammals is called mammalogy. The largest orders of mammals, by number of species, are the rodents, bats, and eulipotyphlans (including hedgehogs, moles and shrews). The next three are the primates (including humans, monkeys and lemurs), the even-toed ungulates (including pigs, bovids and whales), and the Carnivora (including cats, dogs, and seals). Mammals are the only living members of Synapsida; this clade, together with Sauropsida (reptiles and birds), constitutes the larger Amniota clade. Early synapsids are referred to as "pelycosaurs." The more advanced therapsids became dominant during the Guadalupian. Mammals originated from cynodonts, an advanced group of therapsids, during the Late Triassic to Early Jurassic. Mammals achieved their modern diversity in the Paleogene and Neogene periods of the Cenozoic era, after the extinction of non-avian dinosaurs, and have been the dominant terrestrial animal group from 66 million years ago to the present.

Barker was married to Dorothy Jo Gideon from 1945 until her death from lung cancer at age 57 in 1981. From 1983 until his death, Barker was in a long-term relationship with Nancy Burnet, a self-described "radical" animal rights activist nearly 20 years younger than Barker. By mutual decision, Barker and Burnet were never married and lived in separate residences throughout their relationship. Barker had no children with either woman, stating that he had seen friends who had poor relationships with their children and felt like he was too busy to properly raise a child; as of 2007, Barker stated that he had no regrets about his decision. During the early years of his relationship with Burnet, Barker also had a sexual relationship with Dian Parkinson, a model on The Price Is Right; other models on the program noted that the relationship was at one point close enough that there was a realistic chance of the two marrying. Barker and Parkinson's relationship ended acrimoniously along with Parkinson's tenure on the program in 1993. From the late 2000s onward, Burnet described the relationship as a platonic friendship, even as Barker had become more interested in remarrying; she recalled a 2011 incident where Barker drafted a prenuptial agreement for Burnet's lawyer to review and revise as she felt fit, which she refused. Burnet managed Barker's health and diet in retirement.

=== The Middle === Shaffer is most known for his role as Brick Heck in The Middle, which he played throughout the series' entire nine-season run, from 2009 to 2018. In a Wired magazine interview published in January 2013, Shaffer said his role as Brick was similar to his own life, as he is also a "big reader" and "nerd[s] out over the weirdest stuff". In May 2011, a TV Guide article had reported the closeness as well. Brick's characterization, including his idiosyncratic palilalian repetition of words and phrases at the end of sentences, is based on Justin Heisler, the son of The Middle co-creator Eileen Heisler.

Alpha collagen is specifically designed to deliver specific ratios of α- chain peptides as building blocks. The targeted cells can process the α- chain peptides to form triple helix collagen, and replenish the collagen in the targeted site. Scientists believe that Alpha collagen can help to deliver specific ratios of peptides to benefit the targeted cells. Alpha collagen is designed to be used as a supplement for osteoarthritis, based on the theory of the different environments of the extracellular matrix (ECM). The ECM of joint cartilage comprises many classes of macromolecules; collagen (type I, II, VI, X collagen fibrils) and proteoglycans. The ratio and the proportion of collagen play an important role in the tensile and compressive strength, as well as the elasticity of the tissue. The content of collagen in cartilage is different between joints and soft tissue structures. For example, cartilage in the knee has a different structure to the ankle. Cartilage, skin, and spinal discs are subject to continuous regeneration during which anabolic and catabolic processes are in equilibrium. Any imbalance in this equilibrium between matrix degeneration and regeneration results in a decrease in the components of the ECM, and leads to loss of chondral damage. Therefore, it is important to tackle the degenerative process before the inflammatory metalloproteases set in by replenishing the collagen in the ECM. Collagen supplementation has been shown in research studies (in vitro and in vivo) to increase the thickness or volume of the cartilage tissue.

Sources: en.wikipedia.org

Frequently asked questions

Is TB-500 the same substance as thymosin beta-4?

Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.

Why do descriptions of this material differ so much?

The name is a commercial label rather than a systematic chemical designation, so different vendors and papers attach it to different sequences. Some treat it as a fragment and others as the whole protein. Comparing two reports therefore requires checking what each one actually analyzed.

What does a stated purity percentage measure?

Typically it reflects the relative area of the main peak in a reversed-phase chromatogram at a given wavelength. It does not confirm the amino acid sequence, the counter-ion, or the amount of peptide by mass. Identity is normally established by a separate mass measurement.

How is lyophilized TB-500 stored?

The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.

Network